Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, announced the launch of a new program for customers of their SYNTAX ...
The SYNTAX System Delivers DNA On Demand to Enable Labs to Control Their Workflow, Innovate Faster SOUTH SAN FRANCISCO, Calif., and PARIS, May 20, 2021 /PRNewswire/ -- DNA Script, a leading pioneer in ...
DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, announced the launch of a new program for customers of their SYNTAX System, in which organizations receive early access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback